4 hours Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Recommendation of “Buy” by Brokerages MarketBeat
Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine research firms that are currently covering the firm, MarketBeat.com reports. Eight research analysts have rated the…